Analyst firm Jefferies maintains a Buy rating for Denali, expressing 70-80% confidence in FDA approval for the company’s therapy by April 2026. These developments highlight Denali’s ongoing efforts in ...
The J.D. Power 100-Point Score is based on hundreds of thousands of independent and unbiased opinions of verified car owners. Note: J.D. Power ratings reflect our best available data, updated each ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results